See more : First Citizens BancShares, Inc. (FCNCB) Income Statement Analysis – Financial Results
Complete financial analysis of Mountain Valley MD Holdings Inc. (MVMDF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mountain Valley MD Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Nippon Shinyaku Co., Ltd. (NPPNY) Income Statement Analysis – Financial Results
- ABC Gas (International) Limited (ABCGAS.BO) Income Statement Analysis – Financial Results
- AIB Acquisition Corporation (AIBAF) Income Statement Analysis – Financial Results
- Champion Bear Resources Ltd. (CBRSF) Income Statement Analysis – Financial Results
- MPC Container Ships ASA (MPZZF) Income Statement Analysis – Financial Results
Mountain Valley MD Holdings Inc. (MVMDF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.mountainvalleymd.com
About Mountain Valley MD Holdings Inc.
Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation and licensing of its technologies to pharmaceutical, vaccine, and nutraceutical third parties. It offers Quicksome oral drug formulation and delivery technologies; Quicksol solubility formulation technology; and dose sparing adjuvant. In addition, the company is developing IM032 for the treatment of male beagle dogs for comparing intramuscular and subcutaneous dosing. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 60.00K | 0.00 | 110.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 406.00K | 446.00K | 40.00K | 430.19K | 52.16K | 0.00 | 39.70K | 48.02K | 48.00K |
Gross Profit | -346.00K | -446.00K | 70.00K | -430.19K | -52.16K | 0.00 | -39.70K | -48.02K | -48.00K |
Gross Profit Ratio | -576.67% | 0.00% | 63.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 70.00K | 1.47M | 1.18M | 1.36M | 52.16K | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 2.57M | 3.63M | 3.55M | 3.37M | 2.45M | 1.79M | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 200.00K | 0.00 | 0.00 | 0.00 | 570.83K | 317.47K | 0.00 | 0.00 | 0.00 |
SG&A | 2.77M | 3.63M | 3.55M | 3.37M | 3.02M | 887.23K | 923.00K | 747.57K | 1.39M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 60.00K | 5.55M | 5.16M | 5.16M | 3.10M | 887.23K | 923.00K | 747.57K | 1.39M |
Cost & Expenses | 3.25M | 5.55M | 5.16M | 5.16M | 3.15M | 887.23K | 962.70K | 795.59K | 1.43M |
Interest Income | 274.00K | 267.00K | 5.00K | 5.00K | 2.03K | 0.00 | 889.00 | 227.00 | 1.80K |
Interest Expense | 0.00 | 0.00 | 20.18K | 20.00K | 37.24K | 9.80K | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 416.00K | 446.00K | 451.00K | 430.19K | 75.86K | 2.13M | 39.70K | 48.02K | 48.00K |
EBITDA | -2.78M | -5.15M | -9.29M | -4.77M | -3.15M | 0.00 | -923.00K | -747.57K | -1.39M |
EBITDA Ratio | -4,633.33% | 0.00% | -4,411.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -3.19M | -3.50M | -5.28M | -5.28M | -3.23M | -887.23K | -962.70K | -795.59K | -1.43M |
Operating Income Ratio | -5,310.00% | 0.00% | -4,802.23% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -4.58M | -2.23M | -418.00K | -3.41M | -15.62M | -23.52K | 885.00 | 229.00 | 1.80K |
Income Before Tax | -7.76M | -7.33M | -8.14M | -8.14M | -18.84M | -897.03K | -961.82K | -795.36K | -1.43M |
Income Before Tax Ratio | -12,936.67% | 0.00% | -7,402.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -92.00K | 109.00K | -104.82K | -105.00K | -46.09K | -171.86K | 0.00 | 3.00 | 4.00 |
Net Income | -7.67M | -7.44M | -8.14M | -8.14M | -18.84M | -897.03K | -961.82K | -795.36K | -1.43M |
Net Income Ratio | -12,783.33% | 0.00% | -7,402.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.09 | -0.08 | -0.23 | -0.29 | -0.63 |
EPS Diluted | -0.02 | -0.02 | -0.02 | -0.03 | -0.09 | -0.08 | -0.23 | -0.29 | -0.63 |
Weighted Avg Shares Out | 329.67M | 329.65M | 329.24M | 263.51M | 208.41M | 11.72M | 4.20M | 2.78M | 2.28M |
Weighted Avg Shares Out (Dil) | 329.65M | 329.65M | 329.24M | 263.51M | 208.41M | 11.72M | 4.20M | 2.78M | 2.28M |
Mountain Valley MD shares updates from ‘transformative' six months
Mountain Valley MD Provides Business Update, Advances Commercialization
C-SPAN To Visit Contra Costa School, Honor Student Documentary Winners
Mountain Valley MD acquires exclusive license for AgTech product Agrarius
Mountain Valley MD acquires exclusive license for AgTech product Agrarius
Mountain Valley MD Announces Acquisition of Exclusive License for Agrarius, Launch of Performance Guarantee Program
Mountain Valley MD Announces Stock Option Grant
Mountain Valley MD advances commercialization priorities across core business lines
Mountain Valley MD Provides Business Update, Appoints New CFO
Mountain Valley MD to welcome new finance chief in January
Source: https://incomestatements.info
Category: Stock Reports